Dr. Mohammed Bari, M.D.
Psychiatry (Psychiatry Physician)
1908 Sweetwater Rd
National City, CA 91950
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 46
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 415
Licensed in California since 1989, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Psychiatry Physician primary
CA license A46396 (first issued 1989; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Pacific Health Systems LP (17 clinicians)
- Advanced Tms Clinic Inc (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 415
- Services billed
- 2,282
- Patients’ average age
- 68
| Service | Times | Patients |
|---|---|---|
| Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | 1,370 | 187 |
| Established patient office or other outpatient visit, 20-29 minutes | 502 | 95 |
| Injection of drug or substance under skin or into muscle | 262 | 42 |
| Psychiatric diagnostic evaluation with medical services | 177 | 171 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 24 | 20 |
| Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 22 | 14 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Olanzapine Other prescribers in National City, CA | 701 |
| Quetiapine Fumarate Other prescribers in National City, CA | 687 |
| Trazodone Hcl Other prescribers in National City, CA | 499 |
| Benztropine Mesylate Other prescribers in National City, CA | 459 |
| Clozapine Other prescribers in National City, CA | 428 |
| Invega Sustenna (paliperidone palmitate) Other prescribers in National City, CA | 403 |
| Escitalopram Oxalate Other prescribers in National City, CA | 313 |
| Divalproex Sodium Er (divalproex sodium) Other prescribers in National City, CA | 302 |
| Risperidone Other prescribers in National City, CA | 286 |
| Abilify Maintena (aripiprazole) Other prescribers in National City, CA | 204 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 223 payments worth $5,695 in total to this clinician.
| Food and Beverage | $5,595 |
|---|---|
| Education | $101 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. Apr 16, 2025 | Education in-kind | $91.25 |
| Acadia Pharmaceuticals Inc Mar 21, 2025 | Education NUPLAZID · PARKINSONS DISEASE PSYCHOSIS · in-kind | $9.36 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $50,036 in research payments for these studies, mostly to the institutions running them.
- An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication
Sumitomo Pharma America, Inc. · Completed · NCT05741528 - A phase 23 randomized doubleblind placebo controlled study to evaluate the efficacy and safety of oral zavegepant in migraine prevention
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.